Anxiety and mood disorders associated with gonadotropin-releasing hormone agonist therapy

Psychopharmacology Bulletin

Volumn 33, Issue 2, 1997, Pages 311-316

  Warnock, Julia K ^a   Bundren, J Clark ^a  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

Adverse events; Anxiety disorders; GnRH agonist; Mood disorders; Sertraline

Indexed keywords

ESTRADIOL; FOLLITROPIN; GONADORELIN AGONIST; GOSERELIN; LEUPRORELIN; LUTEINIZING HORMONE; SERTRALINE;

ADULT; ANXIETY NEUROSIS; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEPRESSION; ENDOMETRIOSIS; FEMALE; HEADACHE; HORMONAL THERAPY; HORMONE ACTION; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MOOD; OVARY INSUFFICIENCY; PANIC; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY;

1-NAPHTHYLAMINE; ADULT; ANTIDEPRESSIVE AGENTS; ANTINEOPLASTIC AGENTS, HORMONAL; ANXIETY DISORDERS; DEPRESSIVE DISORDER; ENDOMETRIOSIS; FEMALE; HUMANS; LEUPROLIDE; SERTRALINE;

EID: 0030788916     PISSN: 00485764     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. American Psychiatric Association. DSM-IV: Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: The Association, 1994.
2. Bäckström, T. Symptoms related to the menopause and sex steroid treatments. In: Bock, GR, and Goode, JA, eds. Ciba Foundation Symposium 191: Non-Reproductive Actions of Sex Steroids (1995). New York: John Wiley & Sons, 1995. pp.171-186.
3. Barber, HR. Changing concepts in postmenopausal androgen therapy. The Female Patient 16:10-16, 1991.
4. Barbieri, RL. New therapy for endometriosis. N. Engl. J. Med. 318(8):512-514, 1988.
5. Boepple, PA; Mansfield, MJ; Wierman, ME; Rudlin, CR; Bode, HH; Crigler, JF Jr; Crawford, JD; and Crowley, WF Jr. Use of a potent, long acting agonist of gonadotropin-releasing hormone in the treatment of precocious puberty. Endocr. Rev. 7(1):24-33, 1986.
6. Campbell, S, and Whitehead, M. Oestrogen therapy and the menopause syndrome. Clin. Obstet. Gynecol. 4:31-47, 1977.
7. Conn, PM, and Crowley, WF Jr. Gonadotropin-releasing hormone and its analogs. Annu. Rev. Med. 45:391-405, 1994.
8. Damario, MA, and Rock, JA. Goserelin (Zoladex) versus danazol for endometriosis: The North American experience. Br. J. Obstet. Gynaecol. 101[Suppl. 10]:13-18, 1994.
9. de Ziegler, D; Cedars, MI; Randle, D; Lu, JK; Judd, HL; and Meldrum, DR. Suppression of the ovary using a gonadotropin releasing-hormone agonist prior to stimulation for oocyte retrieval. Fertil. Steril. 48(5):807-810, 1987.
10. Dodson, WC; Hughes, CL; Whitesides, DB; and Haney, AF. The effect of leuprolide acetate on ovulation induction with human menopausal gonadotropins in polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 65(1):95-100, 1987.
11. Garner, C. Uses of GnRH agonist. J. Obstet. Gynecol. Neonatal Nurs. 23(7):563-570, 1994.
12. Hamilton, JA; Parry, BL; and Blumenthal, SJ. The menstrual cycle in context, I: Affective syndromes associated with reproductive hormonal changes. J. Clin. Psychiatry 49(12):474-480, 1988.
13. Klaiber, EL; Broverman, DM; Vogel, W; and Kobayashi, Y. Estrogen therapy for severe persistant depression in women. Arch. Gen. Psychiatry 36:550-554, 1979.
14. Labrie, F; Dupont, A; Belanger, A; St-Arnaud, R; Giguere, M; Lacourciere, Y; Edmond, J; and Monfette, G. Treatment of prostate cancer with gonadotropin-releasing hormone agonist. Endocr. Rev. 7(1):67-74, 1986.
15. Lu, PY, and Ory, SJ. Endometriosis: Current management. Mayo Clin. Proc. 70(5):453-463, 1995.
16. Maheux, R. Treatment of uterine leiomyomata: Past, present and future. Horm. Res. 32[Suppl. 1]:125-133, 1989.
17. Montgomery, JC; Appleby, L; Brincat, M; Versi, E; Tapp, A; Fenwick, PB; and Studd, JW. Effects of oestrogen and testosterone implants on psychological disorders in the climacteric. Lancet 1(8528): 297-299, 1987.
18. Neugarten, BL, and Kraines, RJ. Menopausal symptoms in women of various ages. Psychosom. Med. 27:266-273, 1965.
19. O'Hara, MW; Schlechte, JA; Lewis, DA; and Wright, EJ. Prospective study of postpartum blues. Biological and psychosocial factors. Arch. Gen. Psychiatry 48(9):801-806, 1991.
20. Palinkas, LA, and Barrett-Conner, E. Estrogen use and depressive symptoms in postmenopausal women. Obstet. Gynecol. 80(1): 30-36, 1992.
21. Pearlstein, TB. Hormones and depression: What are the facts about premenstrual syndrome, menopause, and hormone replacement therapy? Am. J. Obstet. Gynecol. 173(2):646-653, 1995.
22. Saltiel, E, and Garabedian-Ruffalo, SM. Pharmacologic management of endometriosis. Clin. Pharm. 10(7):518-531, 1991.
23. Shaw, RW, and the Zoladex Endometriosis Study Team. An open randomized comparative study of the effect of goserelin depot and danazol in the treatment of endometriosis. Fertil. Steril. 58(2):265-272, 1992.
24. Sherwin, BB. Affective changes with estrogen and androgen replacement therapy in surgically menopausal women. J. Affect. Disord. 14(2):177-187, 1988.
25. 3H-imipramine binding sites in surgically menopausal women. Biol. Psychiatry 28(4):339-348, 1990.
26. Steingold, KA; Cedars, M; Lu, JK; Randle, D; Judd, HL; and Meldrum, DR. Treatment of endometriosis with a long-acting gonadotropin-releasing hormone agonist. Obstet. Gynecol. 69(3 Pt1):403-411, 1987.
27. Stewart, DE; Boydell, K; Derzko, C; and Marshall, V. Psychologic distress during the menopausal years in women attending a menopause clinic. Int. J. Psychiatry Med. 22(3):213-220, 1992.
28. TAP Pharmaceuticals, Inc. Lupron Depot 3.75 mg Professional Information Brochure, revised April 1995. Lupron Depot manufactured by Takeda Chemical Industries-Ltd. Osaka, Japan, distributed by TAP Pharmaceuticals, Inc. Deerfield, IL.
29. Thomas, EJ. Endometriosis, 1995: Confusion or sense? Int. J. Gynaecol. Obstet. 48(2):149-155, 1995.
30. Weinstock, L, and Cohen, L. Risk of mood disorders throughout the female life cycle. American Society of Clinical Psychopharmacology Progress Notes 6:1-3, 1995.
31. Zeneca Phaimaceuticals. Zoladex 3.6 mg Professional Information Brochure, revised March 1995. Zoladex manufactured by Zeneca LTD, United Kingdom, distributed by Zeneca Phaimaceuticals, Wilmington, DE.